search
Back to results

A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch

Primary Purpose

Hypertension, Cardiac Disease, Surgery

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Omron Wearable Device
Standard Arterial Line
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Hypertension focused on measuring Wearable devices, Blood pressure, Arterial line, Hypertension, Post Operative, Cardiac Surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > 18 years
  • Post-operative cardiac surgery patients on the ICU floors at the Cleveland Clinic Main Campus
  • Wrist size range ranging from 16 cm to 19 cm

Exclusion Criteria:

  • Wrist size range smaller than 16 cm or larger than 19 cm
  • Use of a radial artery graft for coronary artery bypass grafting

Sites / Locations

  • Cleveland Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Omron HeartGuide Smartwatch

Arterial Line

Arm Description

Readings from the Omron HeartGuide Smartwatch

Readings from the arterial line

Outcomes

Primary Outcome Measures

Accuracy of the Omron blood pressure sensor
Omron device accuracy as compared to arterial line BP readings

Secondary Outcome Measures

Full Information

First Posted
June 12, 2019
Last Updated
December 10, 2019
Sponsor
The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT03986281
Brief Title
A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch
Official Title
A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
May 20, 2019 (Actual)
Primary Completion Date
December 10, 2019 (Actual)
Study Completion Date
December 10, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The accuracy of devices like the recent FDA-clearance of the Omron HeartGuide™ Blood Pressure sensor in robust clinical settings remain in question and thus form the underpinning of this research study. The objective of this pilot prospective study is to assess the accuracy of the Omron Blood Pressure sensor as compared to arterial line blood pressure monitoring.
Detailed Description
The purpose of this study is to assess the accuracy of the Omron HeartGuide™ Smartwatch in measuring blood pressure and heart rate as compared to standard post-operative blood pressure and heart rate monitoring with an arterial line and heart monitor. Hypertension affects about 75 million Americans and is the leading cause of cardiovascular disease (heart attacks and strokes), resulting in about 1,000 deaths per day. Only 50% of patients have their blood pressure adequately managed thus necessitating a better solution. Current limitations to hypertension management in non-ICU or non-surgical settings include: 1) infrequent measurements, 2) inherent data variability, 3) white coat hypertension, 4) non-compliance, or 5) poor patient-provider follow-up. A majority of patients have their blood pressure measured only during clinic visits. A wearable blood pressure sensor that takes multiple measurements per day will allow for a new level of granularity among measurements. With more continuous measurements, patients and physicians can work together to identify the onset and progression of hypertension before it causes irreversible damage to the heart, kidneys, and brain. During testing, each subject will wear the Omron HeartGuide™ Smartwatch. Both right and left wrist circumferences will be measured prior to placing the device. All patients will be on continuous telemetry according to standard clinical practice on the ICU. Each patient will be outfitted with the Omron HeartGuide™ Smartwatch (opposite extremity of the arterial line). An Omron BP reading will be obtained at the same time as the arterial line reading. Four readings in total will be obtained for each patient. All four readings may occur on the same day or may be occur over several days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Cardiac Disease, Surgery
Keywords
Wearable devices, Blood pressure, Arterial line, Hypertension, Post Operative, Cardiac Surgery

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Omron HeartGuide Smartwatch
Arm Type
Active Comparator
Arm Description
Readings from the Omron HeartGuide Smartwatch
Arm Title
Arterial Line
Arm Type
Active Comparator
Arm Description
Readings from the arterial line
Intervention Type
Other
Intervention Name(s)
Omron Wearable Device
Intervention Description
Omron wearable device compared to arterial line readings
Intervention Type
Other
Intervention Name(s)
Standard Arterial Line
Intervention Description
Omron wearable device compared to arterial line readings
Primary Outcome Measure Information:
Title
Accuracy of the Omron blood pressure sensor
Description
Omron device accuracy as compared to arterial line BP readings
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years Post-operative cardiac surgery patients on the ICU floors at the Cleveland Clinic Main Campus Wrist size range ranging from 16 cm to 19 cm Exclusion Criteria: Wrist size range smaller than 16 cm or larger than 19 cm Use of a radial artery graft for coronary artery bypass grafting
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Gillinov, M. D.
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30803128
Citation
Kuwabara M, Harada K, Hishiki Y, Kario K. Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-6410T-ZM and HEM-6410T-ZL. J Clin Hypertens (Greenwich). 2019 Jun;21(6):853-858. doi: 10.1111/jch.13499. Epub 2019 Feb 25.
Results Reference
background

Learn more about this trial

A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch

We'll reach out to this number within 24 hrs